Crinetics (CRNX) PT Lowered to $96 at Citizens on Multiple Pivotal Readouts Ahead
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben lowered the price target on Crinetics (NASDAQ: CRNX) to $96.00 (from $105.00) while maintaining a Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
